Meanwhile, RT can enhance the anti-tumor effect of the immune system by up-regulating immunogenic cell surface markers such as intercellular cell adhesion molecule 1 (ICAM-1), major histocompatibility complex class 1 (MHC-1) and Fas (35). This evidence concerns the gene ICAM1 and neoplasm.